AVB vs INBX · P/E 23, rev $3.04B vs rev $1.3M
AvalonBay Communities Inc (AVB) versus Inhibrx Biosciences, Inc. (INBX) — a side-by-side from cached financials, not a winner call.
AvalonBay Communities Inc (AVB) is a reit - residential company listed on US.
Inhibrx Biosciences, Inc. (INBX) is a biotechnology company listed on US.
Latest reported AVB revenue for 2025-12-31 was $3.04B. Net income was $1.06B. Revenue was up 4.4% from 2024-12-31 to 2025-12-31. AVB currently screens at market cap $26.84B and trailing P/E 23.4.
Latest reported INBX revenue for 2025-12-31 was $1.3M. Net income was -$140.1M. Revenue was up 550.0% from 2024-12-31 to 2025-12-31. INBX currently screens at market cap $1.28B.
AVB currently screens at market cap $26.84B and trailing P/E 23.4. INBX currently screens at market cap $1.28B.
Not investment advice. Open the AVB and INBX stock pages for the full models.
Not investment advice.